Registro:

Referencias:

• Sherman, D.G., Dyken, M.L., Gent, M., Harrison, M.J.G., Hart, R.G., Mohr, J.P., Antithrombotic therapy for cerebrovascular disorders: An update (1995) Chest, 108, pp. S444-56
• Collaborative overview of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) Br Med J, 308, pp. 81-106
• Dyken, M.L., Meta-analysis in the assessment of therapy for stroke prevention (1992) Cerebrovasc Dis, 2 (1 SUPPL.), pp. 35-40
• Caplan, L.R., Diagnosis and treatment of ischemic stroke (1991) JAMA, 266, pp. 2413-2418
• Adams, H.P., Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L., Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial (1993) Stroke, 24, pp. 35-41
• Diener, H.C., Cunha, L., Forbes, C., Sivenius, J., Smets, P., Lowenthal, A., European Stroke Prevention Study. II. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke (1996) J Neurol Sci, 143, pp. 1-13
• O'Brien, J.R., How much aspirin? (1990) Thromb Haemost, 64, p. 486
• Akopov, S.S., Grigorian, G.S., Gabrielian, E.S., Dose-dependent aspirin hydrolysis and platelet aggregation in patients with atherosclerosis (1992) J Clin Pharmacol, 32, pp. 133-135
• Hormes, J.T., Austin, J.H., James, G., Toward an optimal 'antiplatelet' dose of aspirin: Preliminary observations (1991) J Stroke Cerebrovasc Dis, 1, pp. 27-35
• Uchiyama, S., Yamazaki, M., Maruyama, S., Shear-induced platelet aggregation and its inhibition by antiplatelet agents in cerebral ischemia (1993) Clin Hemorheol, 13, pp. 623-636
• Uchiyama, S., Yamazaki, M., Maruyama, S., Shear-induced platelet aggregation in cerebral ischemia (1994) Stroke, 25, pp. 1547-1551
• Bernhardt, J., Konstantin, R., Luscher, T.F., Acetylsalicylic acid, at high concentrations, inhibits vascular smooth muscle cell proliferation (1993) J Cardiovasc Pharmacol, 21, pp. 973-976
• Hass, W.K., Easton, J.D., Adams Jr., H.P., A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients (1989) N Engl J Med, 321, pp. 591-597
• The Canadian-American Ticlopidine Study (CATS) in thromboembolic stroke (1989) Lancet, 1, pp. 1215-1220
• Pryse-Phillips, W., Ticlopidine Aspirin Stroke Study: Outcome by vascular distribution of the qualifying event (1993) J Stroke Cerebrovasc Dis, 3, pp. 49-56
• Grotta, J.C., Norris, J.W., Kamm, T.B., Prevention of stroke with ticlopidine: Who benefits most? (1992) Neurology, 42, pp. 111-115
• A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE) (1996) Lancet, 348, pp. 1329-1339
• Álvarez Sabín, J., Ácido acetilsalicílico y triflusal en la prevención del infarto cerebral aterotrombótico (1995) Rev Neurol, 23, pp. 1091-1095
• Jonas, S., Anticoagulant therapy in cerebrovascular disease: Review and meta-analysis (1988) Stroke, 19, pp. 1043-1048
• Rothrock, J.F., Hart, R.G., Antithrombotic therapy in cerebrovascular disease (1991) Ann Intern Med, 115, pp. 885-895
• Feinberg, W.M., Albers, G.W., Barnett, H.J.M., Guidelines for the management of transient ischemic attacks (1994) Stroke, 25, pp. 1320-1333
• Matchar, D.B., McCrory, D.C., Barnett, H.J., Medical treatment for stroke prevention (1994) Ann Intern Med, 121, pp. 41-53
• The feasibility of a collaborative double-blind study using an anticoagulant (1997) Cerebrovasc Dis, 7, pp. 100-112
• Chimowitz, M.I., Kokkinos, J., Strong, J., Brown, M.B., Levine, S.R., Silliman, S., The Warfarin-Aspirin Symptomatic Intracranial Disease Study (1995) Neurology, 45, pp. 1488-1493
• Cardiogenic brain embolism: The second report of the Cerebral Embolism Task Force (1989) Arch Neurol, 46, pp. 727-741
• Bogousslavsky, J., Van Melle, G., Regli, R., Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation: The Lausanne Stroke Registry (1990) Neurology, 40, pp. 1046-1050
• Sandercock, P., Bamford, J., Dennis, M., Atrial fibrillation and stroke: Prevalence in different types of stroke and influence on early and long-term prognosis (1992) Br Med J, 305, pp. 1460-1465
• Martin, R., Bogousslavsky, J., Mechanisms of late stroke after myocardial infarct (1993) J Neurol Neurosurg Psychiatry, 56, pp. 760-764
• Tanne, D., Goldbourt, U., Zion, M., Frequency and prognosis of stroke/TIA among 4,808 survivors of acute myocardial infarction (1993) Stroke, 24, pp. 1490-1495
• Effect of longterm anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction (1994) Lancet, 1, pp. 499-503
• A randomized, controlled trial of aspirin in persons recovered from myocardial infarction (1980) JAMA, 243, pp. 661-669
• Cairns, J.A., Hirsh, J., Lewis, H.D., Antithrombotic agents in coronary artery disease (1992) Chest, 102 (SUPPL.), pp. S456S-81
• Louie, E.K., Konstadt, S.N., Ras, T.L.K., Transesophageal echocardiographic diagnosis of patent foramen ovale in adults without prior stroke (1991) Circulation, 84 (2 SUPPL.), p. 451
• Hart, R.G., Cardiogenic embolism to the brain (1992) Lancet, 339, pp. 589-594
• Amarenco, P., Cohen, A., Tzourio, C., Atherosclerotic disease of the aortic arch and the risk of ischemic stroke (1994) N Engl J Med, 331, pp. 1474-1479
• Einhaupl, K.M., Villringer, A., Meister, W., Mehraein, S., Garner, C., Pellkofer, M., Heparin treatment in sinus venous thrombosis (1991) Lancet, 338, pp. 597-600
• Saver, J.L., Easton, J.D., Hart, R.G., Dissections and trauma of cerebrocervical arteries (1992) Stroke: Pathophysiology, Diagnosis and Management, pp. 670-688. , Barnett HJM, Mohr JP, Stein BM, et al, eds. New York: Churchill-Livingstone
• Hart, R.G., Kanter, M.C., 1990: Hematologic disorders and ischemic stroke: a selective review (1990) Stroke, 21, pp. 1111-1112
• Markus, H.S., Hambley, H., Neurology and the blood: Hematological abnormalities in ischemic stroke (1998) J Neurol Neurosurg Psychiatry, 64, pp. 150-159
• Coull, B.M., Goodnight, S.H., Antiphospholipid antibodies, prethrombotic state, and stroke (1990) Stroke, 21, pp. 1370-1374
• Asherson, R.A., Khamashta, M.A., Ordi-ros, J., The 'primary' antiphospholipid syndrome: Major clinical and serological features (1989) Medicine, 68, pp. 366-374. , Baltimore
• Anticardiolipin antibodies are an independent risk factor for first ischemic stroke (1993) Neurology, 43, pp. 2069-2073
• Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death (1997) Neurology, 47, pp. 91-94
• Levine, S.R., Antiphospholipid antibodies and the nervous system. Clinical features, mechanisms and treatment (1994) Semin Neurol, 14, pp. 168-178
• Bertina, R.M., Koeleman, B.P., Koster, T., Mutation in blood coagulation factor V associated with resistance to activated protein C (1994) Nature, 369, pp. 14-15
• Ridker, P.M., Glynn, R.J., Miletich, J.P., Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation (1997) Ann Intern Med, 126, pp. 528-531
• Thomas, D.P., Roberts, H.R., Hypercoagulability in venous and arterial thrombosis (1997) Ann Intern Med, 126, pp. 638-644
• Mateo, J., Oliver, A., Borrell, M., Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism. Results of the Spanish multicentric study on thrombophilia (EMET-Study) (1997) Thromb Haemost, 77, pp. 444-451
• Ridker, P.M., Hennekens, C.H., Lindpaintner, K., Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men (1995) N Engl J Med, 332, pp. 912-917
• Kontula, K., Ylikorkala, A., Miettinen, H., Arg506Gln factor V mutation (factor V Leiden) in patients with ischemic cerebrovascular disease and survivors of myocardial infarction (1995) Thromb Haemost, 73, p. 558
• Press, R.D., Liu, X.Y., Beamer, N., Ischemic stroke in the elderly. Role of the common factor V Leiden mutation causing resistance to activated protein C (1996) Stroke, 27, pp. 44-48
• Adams Jr., H.P., Brott, T.G., Crowell, R.M., Guidelines for the management of patients with acute ischemic stroke. A statement for health care professionals from a special writing group of the stroke council, American Heart Association (1994) Stroke, 25, pp. 1901-1914
• Sandercock, P.A.G., Van Den Bolt, A.G.M., Lindley, R.I., Antithrombotic therapy in acute ischemic stroke. An overview of the completed randomized trials (1993) J Neurol Neurosurg Psychiatry, 56, pp. 17-25
• Immediate anticoagulation of embolic stroke. A randomized trial (1983) Stroke, 14, pp. 668-676
• Duke, R.J., Bloch, R.F., Turpie, A.G.G., Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. A randomized controlled trial (1986) Ann Intern Med, 105, pp. 825-828
• Kay, R., Wong, K.S., Yu, Y.L., Low molecular weight heparin for the treatment of acute ischemic stroke (1995) N Engl J Med, 333, pp. 1588-1592
• A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke (1997) Lancet, 349, pp. 1569-1581
• Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke (1997) Lancet, 349, pp. 1641-1649
• Low molecular weight heparinoid, Org 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial (1998) JAMA, 279, pp. 1265-1272
• Bousser, M.G., Aspirin or heparin immediately after a stroke? (1997) Lancet, 349, pp. 1564-1565
• Collaborative overview of randomized trials of antiplatelet therapy. III. Reduction in venous thrombosis and pulmonary embolism of antiplatelet prophylaxis among surgical and medical patients (1994) Br Med J, 308, pp. 235-246
• Turpie, A.G.G., Gent, M., Cote, R., A low-molecular weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke (1992) Ann Intern Med, 117, pp. 353-357
• Landefeld, C.S., Goldman, L., Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy (1989) Am J Med, 87, pp. 144-152
• Franke, C.L., De Jonge, J., Van Swieten, J.C., Intracerebral hematomas during anticoagulant treatment (1990) Stroke, 21, pp. 726-730

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------